Related Experiment Video
Updated: Apr 30, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
Cardiomyocyte-specific miRNA-30c over-expression causes dilated cardiomyopathy
Wino J Wijnen1, Ingeborg van der Made2, Stephanie van den Oever2
1Heart Failure Research Center, Academic Medical Center, Amsterdam, The Netherlands; Interuniversitair Cardiologisch Instituut Nederland (ICIN-NHI), Utrecht, The Netherlands.
Overexpressing miRNA-30c in mouse hearts caused dilated cardiomyopathy by impairing mitochondrial function. This study establishes a key in vivo role for microRNA-30c in cardiac physiology and mitochondrial health.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Mitochondrial Medicine
Background:
- MicroRNAs (miRNAs) are crucial regulators of cellular processes, with their dysregulation linked to heart disease.
- MiRNA-30c's role in cardiac physiology is largely unknown, despite its differential expression during heart failure progression.
Purpose of the Study:
- To investigate the in vivo function of miRNA-30c in the heart.
- To elucidate the mechanisms underlying miRNA-30c's impact on cardiac health.
Main Methods:
- Generation of transgenic mice overexpressing miRNA-30c specifically in cardiomyocytes.
- Phenotypic analysis, gene expression profiling, and protein level assessment of mitochondrial oxidative phosphorylation (OXPHOS) complexes.
Main Results:
- Transgenic mice developed severe dilated cardiomyopathy after 6 weeks of age.
- Early analysis revealed disturbed mitochondrial function and downregulation of OXPHOS complexes III and IV.
- Impaired mitochondrial function due to OXPHOS protein depletion was identified as a potential cause of the cardiomyopathy.
Conclusions:
- MiRNA-30c plays a critical in vivo role in maintaining cardiac physiology.
- Dysregulation of miRNA-30c leads to impaired mitochondrial function and dilated cardiomyopathy.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Myocarditis I: Introduction
Cardiomyopathy IV: Restrictive Cardiomyopathy

